Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
The post New patent expiration for Merck Sharp drug REBETOL appeared fi…
New patent expiration for Merck Sharp drug REBETOL Read Post »
Originally published by J. Javier Hernandez, Michael Pryszlak, Lindsay Smith, Connor Yanchus, Naheed Kurji, Vijay M. Shahani and Steven V. Molinski in Front. Oncol., 14 November 2017. Abstract The repositioning or…
The post Giving Drugs a Second…
This is a guest post from Susan K Finston, President of Finston Consulting. A little over five years ago I penned
Biotech in Countries Starting with “I” – Part 12: Israel Read Post »
Biotechnology is a massive scientific field that uses research tools from biology and chemistry to solve problems and that includes human diseases too. Ever since its existence, it has revolutionized…
The post How is biotech combating these five …
How is biotech combating these five killer diseases on the planet? Read Post »
Annual Drug Patent Expirations for GLUCOPHAGE+XR Glucophage Xr is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Bristol Myers drug GLUCOPHAGE X…
New patent expiration for Bristol Myers drug GLUCOPHAGE XR Read Post »
Annual Drug Patent Expirations for NIASPAN Niaspan is a drug marketed by Abbvie and is included in one NDA. It is available from eight suppliers. There is one patent protecting…
The post New patent expiration for Abbvie drug NIASPAN appeared firs…
Annual Drug Patent Expirations for GIAZO Giazo is a drug marketed by Valeant Pharms Intl and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Valeant Pharms drug GIAZO appeared first on…
New patent expiration for Valeant Pharms drug GIAZO Read Post »
Annual Drug Patent Expirations for PULMICORT+FLEXHALER Pulmicort Flexhaler is a drug marketed by Astrazeneca and is included in one NDA. It is available from three suppliers. There are four patents…
The post New patent expiration for Astrazeneca …
New patent expiration for Astrazeneca drug PULMICORT FLEXHALER Read Post »
Health care costs in the US touched a staggering $3.2 trillion in 2015, which makes it one of the nation’s largest industries, equaling 17.8% of gross domestic product. This translates…
The post Factors driving healthcare costs in the US appeared…
NIASPAN (niacin) Abbvie Patent: 6,469,035 Expiration: Mar 15, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Dr…
Drug Patent Expirations for the Week of March 11, 2018 Read Post »
Get new actionable insights and updates from BiotechBlog
